EGFR and lung carcinoma: In pre-TKIs era, young advanced NSCLC patients had better prognosis than older patients.[25] However, in TKIs era, previous study showed that young lung cancer patients with positive EGFR mutant test had only 3.3 months PFS when receiving first-line EGFR-TKIs.